Webinar Event: "Reimbursement Strategies Webinar: Planning Your Payment Strategy in Early Regenerative Medicine Product Development" Presented June 20, 2013 Click here to download the powerpoint slides from the presentation WEBINAR AGENDA…
Webinar Event: "Clinical Trials: Moving Stem Cell based Therapies to the Clinic - Presentations from FDA and Leading Experts" Introduction by Ellen Feigal, M.D., Senior Vice President of…
Title: First-in-Human Trials of Cellular Therapies Speaker: John Hyde, M.D., Ph.D, Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Cellular, Tissue and Gene Therapies (OCTGT),…
Title: Lessons learned from Phase 1 trial of heart-derived stem cells as we move into Phase 2 Speaker: Eduardo Marbán, M.D., Ph.D. Founder and Chairman of Scientific Advisory Board, Capricor,…
Title: Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Trial in 12 Patients Speaker: Jonathan D. Glass, M.D. Professor, Neurology and Pathology,…
The mission of California's Stem Cell Agency (CIRM) is to advance stem cell based science toward clinical trials to create opportunities to bring new effective and curative therapies to…
Developing an idea for a therapy from the lab bench all the way through approval by the Food and Drug Administration is an extremely challenging and complex process. Keith Wells,…
Before bringing a therapy to trials in patients, it must first be tested for safety and effectiveness in animals. Performing these pre-clinical studies for stem cell-based products present added challenges…
Joy Cavagnaro and Keith Wells led the question and answer session for the CIRM-hosted Staying of the Critical Path Workshop which addressed the preclinical, manufacturing and regulatory issues for…
Several clinical trial experts from the United Kingdom spoke at the CIRM-hosted Staying on the Critical Path Workshop to raise awareness about opportunities for California researchers to collaborate on clinical…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
